ARCA biopharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $36.00 Millions, with shareholders equity totaling $32.57 Millions.
The company employs approximately 14 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, ARCA biopharma Inc. reported $- in revenue, generating net income of $-7.20 Millions.
Key financial metrics include a P/E ratio of -5.00, a price-to-book (P/B) ratio of 1.11, and a trailing twelve-month dividend yield of 10,335.00%.
The company trades under the ticker ABIO.